Journal articles on the topic 'Adverse effects/therapeutic use'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Adverse effects/therapeutic use.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Nahata, Milap C. "Antiviral Drugs: Pharmacokinetics, Adverse Effects, and Therapeutic Use." Journal of Pharmacy Technology 3, no. 3 (May 1987): 100–108. http://dx.doi.org/10.1177/875512258700300305.
Full textAttardo, Silvia, Olimpia Musumeci, Daniele Velardo, and Antonio Toscano. "Statins Neuromuscular Adverse Effects." International Journal of Molecular Sciences 23, no. 15 (July 28, 2022): 8364. http://dx.doi.org/10.3390/ijms23158364.
Full textSpahn, Joseph D., and Alan K. Kamada. "Special Considerations in the Use of Glucocorticoids in Children." Pediatrics In Review 16, no. 7 (July 1, 1995): 266–72. http://dx.doi.org/10.1542/pir.16.7.266.
Full textGrbovic, Leposava, and Miroslav Radenkovic. "Therapeutic use of glucocorticoids and immunosuppressive agents." Srpski arhiv za celokupno lekarstvo 133, Suppl. 1 (2005): 67–73. http://dx.doi.org/10.2298/sarh05s1067g.
Full textJabbour, Serge A. "The Importance of Reducing Hyperglycemia While Preserving Insulin Secretion—The Rationale for Sodium-coupled Glucose Co-transporter 2 Inhibition in Diabetes." US Endocrinology 05, no. 01 (2009): 75. http://dx.doi.org/10.17925/use.2009.05.1.75.
Full textSalman, Saad, Sayyed Muhammad Ashhad Halimi, and Inzemam Khan. "Olanzapine Use in Schizophrenia and the Modulation of Its Response by Genetic Variations." Molecular Medicine Communications 2, no. 01 (June 30, 2022): 43–76. http://dx.doi.org/10.55627/mmc.002.001.0038.
Full textSirasanagandla, Srinivasa Rao, Isehaq Al-Huseini, Hussein Sakr, Marzie Moqadass, Srijit Das, Norsham Juliana, and Izuddin Fahmy Abu. "Natural Products in Mitigation of Bisphenol A Toxicity: Future Therapeutic Use." Molecules 27, no. 17 (August 24, 2022): 5384. http://dx.doi.org/10.3390/molecules27175384.
Full textHuestis, Marilyn A., Renata Solimini, Simona Pichini, Roberta Pacifici, Jeremy Carlier, and Francesco Paolo Busardò. "Cannabidiol Adverse Effects and Toxicity." Current Neuropharmacology 17, no. 10 (September 13, 2019): 974–89. http://dx.doi.org/10.2174/1570159x17666190603171901.
Full textSiroka, Z., and Z. Svobodova. "The toxicity and adverse effects of selected drugs in animals – overview." Polish Journal of Veterinary Sciences 16, no. 1 (March 1, 2013): 181–91. http://dx.doi.org/10.2478/pjvs-2013-0027.
Full textWalczewska, Sylwia, and Agata Wawrzyniak. "N-acetylcysteine in clinical practice – properties, use and adverse effects." Pediatria i Medycyna Rodzinna 16, no. 3 (October 30, 2020): 243–46. http://dx.doi.org/10.15557/pimr.2020.0044.
Full textOkaiyeto, Kunle, and Oluwafemi O. Oguntibeju. "African Herbal Medicines: Adverse Effects and Cytotoxic Potentials with Different Therapeutic Applications." International Journal of Environmental Research and Public Health 18, no. 11 (June 2, 2021): 5988. http://dx.doi.org/10.3390/ijerph18115988.
Full textGupta, Jeetendra Kumar. "Emergence of Synthetic Cannabinoids: Pharmacological insights and adverse effects." Research Journal of Chemistry and Environment 27, no. 1 (December 15, 2022): 120–28. http://dx.doi.org/10.25303/2701rjce1200128.
Full textMadruga, GM, LZ Crivellenti, S. Borin-Crivellenti, CA Cintra, LG Gomes, and PR Spiller. "Comparative use of dimethyl sulphoxide (DMSO) in different animal species." Veterinární Medicína 62, No. 4 (April 10, 2017): 179–85. http://dx.doi.org/10.17221/176/2015-vetmed.
Full textTromp, Angelino T., Yuxi Zhao, Ilse Jongerius, Erik C. J. M. Heezius, Pauline Abrial, Maartje Ruyken, Jos A. G. van Strijp, et al. "Pre-existing antibody-mediated adverse effects prevent the clinical development of a bacterial anti-inflammatory protein." Disease Models & Mechanisms 13, no. 9 (May 29, 2020): dmm045534. http://dx.doi.org/10.1242/dmm.045534.
Full textPaul, Alok K., Craig M. Smith, Mohammed Rahmatullah, Veeranoot Nissapatorn, Polrat Wilairatana, Mariana Spetea, Nuri Gueven, and Nikolas Dietis. "Opioid Analgesia and Opioid-Induced Adverse Effects: A Review." Pharmaceuticals 14, no. 11 (October 27, 2021): 1091. http://dx.doi.org/10.3390/ph14111091.
Full textNatalia González-Quero and Pilar Martínez. "Bioactive compounds in some principal mushrooms: An association to adverse effects." GSC Advanced Research and Reviews 5, no. 2 (November 30, 2020): 031–47. http://dx.doi.org/10.30574/gscarr.2020.5.2.0103.
Full textStoner, Steven C. "Management of serious cardiac adverse effects of antipsychotic medications." Mental Health Clinician 7, no. 6 (November 1, 2017): 246–54. http://dx.doi.org/10.9740/mhc.2017.11.246.
Full textParolaro, Daniela. "Therapeutic and toxicological aspects of the use of cannabis and cannabinoids in medicine." Rendiconti Lincei. Scienze Fisiche e Naturali 32, no. 1 (January 21, 2021): 17–23. http://dx.doi.org/10.1007/s12210-020-00968-w.
Full textSoler-Cedeno, Omar, and Zheng-Xiong Xi. "Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge." Cells 11, no. 20 (October 17, 2022): 3262. http://dx.doi.org/10.3390/cells11203262.
Full textHolt, Curtis D., Gordon Ingle, and Theodore M. Sievers. "Inhibitors of Calcineurin." Journal of Pharmacy Practice 16, no. 6 (December 2003): 414–33. http://dx.doi.org/10.1177/0897190003260317.
Full textBubnova, Marina G. "Adverse effects of statin therapy: real evidence." CardioSomatics 10, no. 1 (March 15, 2019): 51–61. http://dx.doi.org/10.26442/22217185.2019.1.190264.
Full textPichini, Simona, Alfredo Fabrizio Lo Faro, Francesco Paolo Busardò, and Raffaele Giorgetti. "Medicinal Cannabis and Synthetic Cannabinoid Use." Medicina 56, no. 9 (September 7, 2020): 453. http://dx.doi.org/10.3390/medicina56090453.
Full textDel Rosso, James. "Clinically Important Considerations with the Use of Oral Doxycycline." SKIN The Journal of Cutaneous Medicine 1, no. 3 (November 13, 2017): 143–47. http://dx.doi.org/10.25251/skin.1.3.4.
Full textMaksimov, M. L., N. M. Kiseleva, D. G. Semenikhin, and B. K. Romanov. "Adverse reactions with the use of non-steroidal anti-inflammatory drugs." Vrač skoroj pomoŝi (Emergency Doctor), no. 8 (August 1, 2020): 35–50. http://dx.doi.org/10.33920/med-02-2008-02.
Full textMonteiro-Oliveira, Bruno B., Ana Carolina Coelho-Oliveira, Tatiane S. A. David, Adriana T. Brito, Ana Carla A. Cruz, Genice G. Souza, and Laisa L. Paineiras-Domingos. "The therapeutic use of essential oils in the care of cancer patients in chemotherapy: A systematic review." Brazilian Journal of Health and Biomedical Sciences 20, no. 1 (May 13, 2021): 36–45. http://dx.doi.org/10.12957/bjhbs.2021.59744.
Full textBreijyeh, Zeinab, Buthaina Jubeh, Sabino A. Bufo, Rafik Karaman, and Laura Scrano. "Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses." Toxins 13, no. 2 (February 5, 2021): 117. http://dx.doi.org/10.3390/toxins13020117.
Full textde Leve, Simone, Florian Wirsdörfer, and Verena Jendrossek. "The CD73/Ado System—A New Player in RT Induced Adverse Late Effects." Cancers 11, no. 10 (October 16, 2019): 1578. http://dx.doi.org/10.3390/cancers11101578.
Full textMcCormack, Ann. "Temozolomide in the Treatment of Aggressive Pituitary Tumors—An Overview of Existing Knowledge and Future Perspectives." US Endocrinology 08, no. 02 (2012): 112. http://dx.doi.org/10.17925/use.2012.08.02.112.
Full textKichloo, Asim, Michael Albosta, Michael Aljadah, Zain El-Amir, Ghazaleh Goldar, Muhammed Zatmar Khan, Dushyant Singh Dahiya, Srilakshmi Vallabhaneni, Farah Wani, and Jagmeet Singh. "Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility." SAGE Open Medicine 9 (January 2021): 205031212110009. http://dx.doi.org/10.1177/20503121211000909.
Full textSantos, Ana Cláudia, Miguel Pereira-Silva, Catarina Guerra, Diana Costa, Diana Peixoto, Irina Pereira, Inês Pita, António J. Ribeiro, and Francisco Veiga. "Topical Minoxidil-Loaded Nanotechnology Strategies for Alopecia." Cosmetics 7, no. 2 (March 27, 2020): 21. http://dx.doi.org/10.3390/cosmetics7020021.
Full textGong, Guifang, Bailing Fu, Caixin Ying, Zhiqin Zhu, Xiaoqian He, Yingying Li, Zhuanxing shen, et al. "Targeted delivery of paclitaxel by functionalized selenium nanoparticles for anticancer therapy through ROS-mediated signaling pathways." RSC Advances 8, no. 70 (2018): 39957–66. http://dx.doi.org/10.1039/c8ra07539e.
Full textMerzlyak, E. M., D. S. Syrko, E. A. Musatkina, and M. A. Israelson. "The use of monoclonal antibodies in autoimmunity treatment." NANOMEDICINE, no. 6 (December 31, 2018): 150–54. http://dx.doi.org/10.24075/brsmu.2018.094.
Full textAcosta, Leslie Del Carmen Luza, and Carla Aparecida Arena Ventura. "Scientific evidence on therapeutic marihuana use in individuals treated in Health Care Services." SMAD Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português) 13, no. 3 (August 27, 2018): 167–74. http://dx.doi.org/10.11606/issn.1806-6976.v13i3p167-174.
Full textLee, Gihyun, and Hyunsu Bae. "Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression." BioMed Research International 2017 (2017): 1–11. http://dx.doi.org/10.1155/2017/6596241.
Full textIto, Matthew K. "Statin Drug Interactions in Patients with Comorbidities and on Multiple Medications." US Endocrinology 08, no. 02 (2012): 104. http://dx.doi.org/10.17925/use.2012.08.02.104.
Full textSimões, G., S. Jesus, and R. Silva. "Therapeutic use of ayahuasca: a review of the evidence of its use in approaching depressive disorders." European Psychiatry 65, S1 (June 2022): S715. http://dx.doi.org/10.1192/j.eurpsy.2022.1843.
Full textKalant, Harold. "Medicinal Use of Cannabis: History and Current Status." Pain Research and Management 6, no. 2 (2001): 80–91. http://dx.doi.org/10.1155/2001/469629.
Full textShapiro, Evelyn. "Hospital Use by Elderly Manitobans Resulting From An Injury." Canadian Journal on Aging / La Revue canadienne du vieillissement 7, no. 2 (1988): 125–33. http://dx.doi.org/10.1017/s0714980800007364.
Full textGliszczyńska, Anna, and Marta Nowaczyk. "Lipid Formulations and Bioconjugation Strategies for Indomethacin Therapeutic Advances." Molecules 26, no. 6 (March 12, 2021): 1576. http://dx.doi.org/10.3390/molecules26061576.
Full textWeinberg, Mea A., and Michael Bral. "Tetracycline and Its Analogues: a Therapeutic Paradigm in Periodontal Diseases." Critical Reviews in Oral Biology & Medicine 9, no. 3 (July 1998): 322–32. http://dx.doi.org/10.1177/10454411980090030501.
Full textZothantluanga, James H., Hannah S. Lalnunpuii, Hans Raj Bhat, and Anshul Shakya. "Awareness on the possible adverse effects of Garcinia cambogia: A scientific approach." Science Vision 19, no. 4 (December 31, 2020): 120–33. http://dx.doi.org/10.33493/scivis.19.04.02.
Full textTsapakis, E. M., Z. Gamie, G. T. Tran, S. Adshead, A. Lampard, A. Mantalaris, and E. Tsiridis. "The adverse skeletal effects of selective serotonin reuptake inhibitors." European Psychiatry 27, no. 3 (April 2012): 156–69. http://dx.doi.org/10.1016/j.eurpsy.2010.10.006.
Full textFassakhov, R. S., and D. I. Marapov. "Mometasone furoate in the treatment of allergic rhinitis: a complex therapeutic effect." Meditsinskiy sovet = Medical Council, no. 12 (September 19, 2021): 130–37. http://dx.doi.org/10.21518/2079-701x-2021-12-130-137.
Full textGotti, Manuel, Valeria Fiaccadori, Elisa Bono, Benedetta Landini, Marzia Varettoni, Luca Arcaini, and Maurizio Bonfichi. "Therapy-Related Late Adverse Events in Hodgkin’s Lymphoma." Lymphoma 2013 (April 11, 2013): 1–7. http://dx.doi.org/10.1155/2013/952698.
Full textD'Agostino, Giovanni Marco, Giulio Rizzetto, Andrea Marani, Samuele Marasca, Matteo Candelora, Daisy Gambini, Helena Gioacchini, et al. "Bullous Pemphygoid and Novel Therapeutic Approaches." Biomedicines 10, no. 11 (November 8, 2022): 2844. http://dx.doi.org/10.3390/biomedicines10112844.
Full textVassal, Mariana, Sandra Rebelo, and Maria de Lourdes Pereira. "Metal Oxide Nanoparticles: Evidence of Adverse Effects on the Male Reproductive System." International Journal of Molecular Sciences 22, no. 15 (July 28, 2021): 8061. http://dx.doi.org/10.3390/ijms22158061.
Full textMantle, David, and Marcel G. Smits. "Melatonin for the treatment of gastrointestinal disorders: an overview." Gastrointestinal Nursing 19, no. 3 (April 2, 2021): 18–22. http://dx.doi.org/10.12968/gasn.2021.19.3.18.
Full textRavindran, A. V., R. J. Bialik, and Y. D. Lapierre. "Therapeutic Efficacy of Specific Serotonin Reuptake Inhibitors (SSRIs) in Dysthymia." Canadian Journal of Psychiatry 39, no. 1 (February 1994): 21–26. http://dx.doi.org/10.1177/070674379403900106.
Full textWan Mohd Tajuddin, Wan Nur Baitty, Nordin H. Lajis, Faridah Abas, Iekhsan Othman, and Rakesh Naidu. "Mechanistic Understanding of Curcumin’s Therapeutic Effects in Lung Cancer." Nutrients 11, no. 12 (December 6, 2019): 2989. http://dx.doi.org/10.3390/nu11122989.
Full textAl-Roubaie, Zanab, Elena Guadagno, Agnihotram V. Ramanakumar, Afsheen Q. Khan, and Kenneth A. Myers. "Clinical utility of therapeutic drug monitoring of antiepileptic drugs." Neurology: Clinical Practice 10, no. 4 (September 6, 2019): 344–55. http://dx.doi.org/10.1212/cpj.0000000000000722.
Full text